BRIEF published on 10/04/2024 at 10:06, 1 year 6 months ago Aspermont Ltd. Sees Growth After Challenging First Half of 2024 BUY Rating Aspermont Ltd. Q3 2024 Growth Strategic Recruitment Revenue Quality
BRIEF published on 10/04/2024 at 10:06, 1 year 6 months ago Aspermont Ltd. connaît une croissance après un premier semestre 2024 difficile Acheter Une Note Recrutement Stratégique Aspermont Ltée. Croissance Au 3e Trimestre 2024 Qualité Des Revenus
PRESS RELEASE published on 10/04/2024 at 10:02, 1 year 6 months ago Original-Research: Aspermont Ltd. (von GBC AG): Kaufen Aspermont Ltd. veröffentlichte eine neue Studie von GBC AG, die eine Wachstumserholung und strategische Rekrutierungen hervorhebt. Starke Liquidität und Umsatzwachstum im Jahresvergleich GBC AG Umsatzwachstum Aspermont Ltd. Wachstumserholung Liquidität
PRESS RELEASE published on 10/04/2024 at 10:01, 1 year 6 months ago Original-Research: Aspermont Ltd. (von GBC AG): Buy Aspermont Ltd. shows growth potential post-challenging H1 2024 with strong cash position and revenue increase. Analysts recommend buying with revised target price Revenue Increase Cash Position BUY Rating Growth Potential Aspermont Ltd.
BRIEF published on 03/12/2024 at 12:06, 2 years ago Aspermont Ltd. obtient la note « Acheter » de GBC AG avec un prix cible ajusté Aspermont Ltée Acheter Une Évaluation Ajustement Du Prix Cible Croissance À Deux Chiffres Recrutement Stratégique
BRIEF published on 03/12/2024 at 12:06, 2 years ago Aspermont Ltd. Garners "Buy" Rating from GBC AG with Adjusted Target Price BUY Rating Target Price Adjustment Double-digit Growth Aspermont Ltd Strategic Hiring
PRESS RELEASE published on 03/12/2024 at 12:02, 2 years ago Original-Research: Aspermont Ltd. (von GBC AG): Kaufen GBC AG stuft Aspermont Ltd. positiv ein und empfiehlt den Kauf. Das Unternehmen verzeichnet kontinuierliches Wachstum mit Fokus auf langfristige Strategie. Neue Geschäftsfelder und Investitionen werden positiv bewertet Kursziel GBC AG Wachstum Aspermont Ltd. Investitionen
PRESS RELEASE published on 03/12/2024 at 12:01, 2 years ago Original-Research: Aspermont Ltd. (von GBC AG): Buy GBC AG releases research report on Aspermont Ltd., recommending a buy with a target price of 0.07 AUD by 31.12.2024. Company shows continued growth and capital efficiency Buy Recommendation GBC AG Research Report Aspermont Ltd. Capital Efficiency
PRESS RELEASE published on 08/28/2023 at 12:02, 2 years 7 months ago Original-Research: Aspermont Ltd (von GBC AG): Buy
PRESS RELEASE published on 08/28/2023 at 12:01, 2 years 7 months ago Original-Research: Aspermont Ltd (von GBC AG): Kaufen
Published on 04/07/2026 at 15:00, 2 hours 26 minutes ago Karbon-X Expands Enterprise Climate Platform Through Strategic Partnership with carbon-connect AG
Published on 04/07/2026 at 14:45, 2 hours 41 minutes ago Predictiv AI Introduces Clinical AI Reasoning Platform, Files Patent for Domain-Specific Clinical AI Methodology
Published on 04/07/2026 at 14:40, 2 hours 46 minutes ago bioEnergy Development Inc. Advances Domestic Activated Carbon Production Worth Up to $30 Million Over 5 Years
Published on 04/07/2026 at 14:30, 2 hours 56 minutes ago Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides
Published on 04/07/2026 at 14:30, 2 hours 56 minutes ago Sekur Private Data Announces Philip Oakley and Kenneth Rogers as Members of Strategic Advisory Board
Published on 04/07/2026 at 16:32, 53 minutes ago Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.
Published on 04/07/2026 at 16:30, 55 minutes ago From Old Channel to New Garden: How Chaoyang’s 'Sakura River' is Dazzling Spring
Published on 04/07/2026 at 15:00, 2 hours 26 minutes ago Amrize Announces Date for First Quarter 2026 Financial Results
Published on 04/07/2026 at 14:55, 2 hours 30 minutes ago Original-Research: Delticom AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 04/07/2026 at 14:42, 2 hours 43 minutes ago Evotec to Receive Approx. $100 Million as Part of Tubulis Acquisition
Published on 04/07/2026 at 16:43, 42 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010318386
Published on 04/07/2026 at 16:43, 42 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010318386
Published on 04/07/2026 at 16:18, 1 hour 7 minutes ago NRJ Group - Information relative aux droits de vote au 31.03.2026 (French & English)
Published on 04/07/2026 at 14:44, 2 hours 41 minutes ago Statement of transactions in own shares from March 30, 2026 to April 2, 2026
